Cargando…
A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity
BACKGROUND: Glioma is one of the most aggressive malignant brain tumors that is characterized with inevitably infiltrative growth and poor prognosis. ARST is a novel lncRNA whose expression level is significantly decreased in the patients with glioblastoma multiforme. However, the exact mechanisms o...
Autores principales: | Sun, Jun, He, Dong, Fu, Yibing, Zhang, Rui, Guo, Hua, Wang, Zhaojuan, Wang, Yanan, Gao, Taihong, Wei, Yanbang, Guo, Yuji, Pang, Qi, Liu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183030/ https://www.ncbi.nlm.nih.gov/pubmed/34099027 http://dx.doi.org/10.1186/s13046-021-01977-9 |
Ejemplares similares
-
LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer
por: Dong, Lujia, et al.
Publicado: (2022) -
LncRNA ZNF674-AS1 regulates granulosa cell glycolysis and proliferation by interacting with ALDOA
por: Li, Duan, et al.
Publicado: (2021) -
LncRNA HSP90AA1-IT1 promotes gliomas by targeting miR-885-5p-CDK2 pathway
por: Gao, Taihong, et al.
Publicado: (2017) -
LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis
por: Shen, Yifei, et al.
Publicado: (2020) -
Actin cytoskeleton in angiogenesis
por: Yadunandanan Nair, Nidhi, et al.
Publicado: (2022)